These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 20451605)

  • 1. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
    Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
    Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors.
    Zhang W; Shi Y; Chen Y; Ye J; Sha X; Fang X
    Biomaterials; 2011 Apr; 32(11):2894-906. PubMed ID: 21256584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
    Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
    Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
    Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
    Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
    Han LM; Guo J; Zhang LJ; Wang QS; Fang XL
    Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery.
    Li M; Liu Y; Feng L; Liu F; Zhang L; Zhang N
    Colloids Surf B Biointerfaces; 2015 Jul; 131():191-201. PubMed ID: 25988283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.
    Zhang W; Shi Y; Chen Y; Hao J; Sha X; Fang X
    Biomaterials; 2011 Sep; 32(25):5934-44. PubMed ID: 21596432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
    Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C
    Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
    Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
    Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
    Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
    Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antiproliferative and apoptosis effect of paclitaxel-loaded polymeric micelles against non-small cell lung cancers.
    Zhang XY; Zhang YD
    Tumour Biol; 2015 Jul; 36(7):4949-59. PubMed ID: 25702089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X; Mo R; Ding Y; Zheng W; Zhang C
    Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
    Xie X; Shao X; Ma W; Zhao D; Shi S; Li Q; Lin Y
    Nanoscale; 2018 Mar; 10(12):5457-5465. PubMed ID: 29484330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
    Gill KK; Kaddoumi A; Nazzal S
    Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
    Shen J; Yin Q; Chen L; Zhang Z; Li Y
    Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
    Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
    Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.